rxstat › Shortages › Atomoxetine

Atomoxetine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Atomoxetine products are in shortage in Canada (13 of 63 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.
Products affected
13 of 63
In shortage since
Jun 2, 2025
Est. full return
Dec 31, 2026
Reports on file
178
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-ATOMOXETINE
40MG · CAPSULE · APOTEX INC
DIN 02318059 · since Jun 30, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-ATOMOXETINE
18MG · CAPSULE · TEVA CANADA LIMITED
DIN 02314568 · since Apr 30, 2026, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
RIVA-ATOMOXETINE
25MG · CAPSULE · LABORATOIRE RIVA INC.
DIN 02405989 · since ?, no end estimate · Delay in shipping of the drug.
Active shortage
RIVA-ATOMOXETINE
40MG · CAPSULE · LABORATOIRE RIVA INC.
DIN 02405997 · since Jun 2, 2025, no end estimate · Demand increase for the drug.
Active shortage
TEVA-ATOMOXETINE
60MG · CAPSULE · TEVA CANADA LIMITED
DIN 02314592 · since Jun 3, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-ATOMOXETINE
60MG · CAPSULE · APOTEX INC
DIN 02318067 · since May 19, 2026, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP ATOMOXETINE
100MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02506874 · since Mar 12, 2026, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP ATOMOXETINE
80MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02506866 · since Mar 12, 2026, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP ATOMOXETINE
18MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02506815 · since Mar 12, 2026, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-ATOMOXETINE
10MG · CAPSULE · TEVA CANADA LIMITED
DIN 02314541 · since Sep 17, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-ATOMOXETINE
60MG · CAPSULE · PHARMASCIENCE INC
DIN 02381060 · since Sep 15, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-ATOMOXETINE
25MG · CAPSULE · PHARMASCIENCE INC
DIN 02381044 · since Sep 15, 2025, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Atomoxetine is currently affected by 13 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED, LABORATOIRE RIVA INC., JAMP PHARMA CORPORATION and 1 others.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug; demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Atomoxetine is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).

Recent changes

Common questions

When will Atomoxetine be back in stock in Canada?

The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Atomoxetine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (psychostimulants and nootropics)

Partial shortageDextroamphetamine2 of 6 reported products affected · est. return Jul 20, 2026Partial shortageLisdexamfetamine3 of 18 reported products affected · est. return Jul 24, 2026Partial shortageMethylphenidate7 of 59 reported products affected · est. return Oct 3, 2026Partial shortageMixed Salts Amphetamine3 of 25 reported products affected · est. return Jun 19, 2026Partial shortageModafinil1 of 6 reported products affectedNo current shortageCaffeine

All psychostimulants and nootropics shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.